Literature DB >> 21154258

Active infective endocarditis: Clinical characteristics and factors related to hospital mortality.

Carlo Rostagno1, Gabriele Rosso, Francesco Puggelli, Sandro Gelsomino, Lucio Braconi, Gian Franco Montesi, Stefano Romagnoli, Pier Luigi Stefano, Gian Franco Gensini.   

Abstract

BACKGROUND: Little information exists on the clinical characteristics and factors related to hospital mortality in patients with active infective endocarditis referred for surgery.
METHODS: Between January 1, 2003 and December 31, 2006, 86 patients (56 males, 30 females, mean age 59.2 years) with active infective endocarditis were referred to our Department (2.8% of overall hospitalizations). The relation of several clinical, laboratory and echocardiographic findings at admission with hospital mortality was evaluated.
RESULTS: A native valve (NVE) was involved in 50/86; the other 30 had a prosthetic valve endocarditis (PVE). Six had pacemaker endocarditis. The aortic valve was involved more frequently than the mitral valve, both in NVE and PVE. The tricuspid valve was involved in four drug addicts; 51% of patients were in NYHA class III-IV. Staphylococci and streptococci were isolated in 69% of patients (39% vs 30%). Blood cultures were negative in 24%. Overall hospital mortality has been 11.6%. Two patients died before surgery, eight in the perioperative period. Hospital mortality was closely related to age, clinical and laboratory evidence of advanced septic condition (temperature > 38°C, leukocytosis and creatinine > 2.0 mg/dL) and hemodynamic impairment.
CONCLUSIONS: Active infective endocarditis is a significant cause of referral to heart surgery departments and hospital mortality is still > 10%. Clinical and laboratory parameters easily available at admission suggest that severe sepsis and/or hemodynamic impairment may be helpful in predicting the clinical outcome in this group of high risk patients.

Entities:  

Mesh:

Year:  2010        PMID: 21154258

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  9 in total

1.  Tricuspid Endocarditis and Septic Pulmonary Embolism in an Intravenous Drug User with advanced HIV Infection.

Authors:  Kadriye Kart Yasar; Filiz Pehlivanoglu; Sevtap Gursoy; Gonul Sengoz
Journal:  Oman Med J       Date:  2011-09

Review 2.  The causative agents in infective endocarditis: a systematic review comprising 33,214 cases.

Authors:  Christiana T Vogkou; Nikolaos I Vlachogiannis; Leonidas Palaiodimos; Antonis A Kousoulis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-11       Impact factor: 3.267

Review 3.  Infective endocarditis in intravenous drug abusers: an update.

Authors:  C Sousa; C Botelho; D Rodrigues; J Azeredo; R Oliveira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-20       Impact factor: 3.267

4.  Maternal understanding of infective endocarditis after hospitalization: assessing the knowledge of mothers of children with congenital heart disease and the practical implications.

Authors:  Anja Knöchelmann; Siegfried Geyer; Urte Grosser
Journal:  Pediatr Cardiol       Date:  2013-08-27       Impact factor: 1.655

5.  A Study of Clinical, Microbiological, and Echocardiographic Profile of Patients of Infective Endocarditis.

Authors:  Soumik Ghosh; Ratnakar Sahoo; Ranjit Kumar Nath; Nandini Duggal; Adesh Kumar Gadpayle
Journal:  Int Sch Res Notices       Date:  2014-11-04

6.  Early results for active infective endocarditis.

Authors:  Mahdi Aithoussa; Noureddine Atmani; Reda Mounir; Younes Moutakiallah; Mehdi Bamous; Abdessamad Abdou; Fouad Nya; Anis Seghrouchni; Siham Bellouize; Mohamed Drissi; Mostafa Elouennass; Youssef Elbekkali; Abdelatif Boulahya
Journal:  Pan Afr Med J       Date:  2017-11-21

7.  Clinical Features and Outcome of Infective Endocarditis in a University Hospital in Romania.

Authors:  Emilia Elena Babeș; Diana Anca Lucuța; Codruța Diana Petcheși; Andreea Atena Zaha; Cristian Ilyes; Alexandru Daniel Jurca; Cosmin Mihai Vesa; Dana Carmen Zaha; Vlad Victor Babeș
Journal:  Medicina (Kaunas)       Date:  2021-02-10       Impact factor: 2.430

8.  Cystatin C in a composite risk score for mortality in patients with infective endocarditis: a cohort study.

Authors:  Christian Bjurman; Ulrika Snygg-Martin; Lars Olaison; Michael L X Fu; Ola Hammarsten
Journal:  BMJ Open       Date:  2012-07-12       Impact factor: 2.692

Review 9.  Infective endocarditis epidemiology over five decades: a systematic review.

Authors:  Leandro Slipczuk; J Nicolas Codolosa; Carlos D Davila; Abel Romero-Corral; Jeong Yun; Gregg S Pressman; Vincent M Figueredo
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.